Subscribe to our Newsletters !!

    Kumar Jeetendra

    Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult

    Nottingham, UK – 2nd February 2021 – Life Science Newswire – Albumedix Ltd. (‘Albumedix’), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with the Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based

    Solid Phase Extraction Microplate Selection Guide

    Porvair Sciences announce the availability of a new guide that makes selection of the optimum Solid Phase Extraction (SPE) microplate for your application both quick and easy. SPE is a widely used method of sample preparation that concentrates and purifies analytes from a solution by means of absorption, followed by the elution of the analyte

    Possible antiviral treatment for COVID-19 recognized

    Researchers have identified an antiviral drug that’s highly effective against the COVID-19 causing coronavirus, and may have significant implications in how future disease outbreaks are handled. The team, including researchers at the University of Nottingham in the UK, found that the plant-derived antiviral, in small doses, triggers an extremely effective broad-spectrum host-centred antiviral innate immune

    Childhood diet can modify the gut microbiome for life

    Eating too much fat and sugar for a child can alter your microbiome for life, even if you later learn to eat healthier, a new study in mice suggests. The study by UC Riverside researchers is among the first to demonstrate a significant decrease in the total number and diversity of gut bacteria in mature

    BD Announces Assay for Identification of COVID-19 Patients

    EYSINS, Switzerland, February 03, 2021/BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE mark of BD Multitest™ 6-Color TBNK Reagent with BD Trucount™ Tubes with expanded clinical application to help clinicians identify COVID-19 patients at increased relative risk of intubation with mechanical ventilation (IMV) and mortality at

    Glenmark Pharma gets USFDA gesture for seizure treatment drug

    Drug major Glenmark Pharma on Wednesday said it has received final approval from the US health regulator for Topiramate extended-release capsules, used to treat certain types of seizures. The approved product is a generic version of Qudexy XR Capsules of Upsher-Smith Laboratories, LLC. Glenmark Pharmaceuticals Ltd has received final approval from the United States Food

    World first – biological evidence reveals scalp cooling physically protects hair from chemotherapy

    Huddersfield, UK – 4 February 2021  – Groundbreaking research, announced ahead of World Cancer Day 2021, proves that scalp cooling physically protects hair follicles from chemotherapy drugs. It is the world’s first piece of biological evidence that explains how scalp cooling actually works and the mechanism behind its protection of the hair follicle. The study,

    Serum Institute of India postpones antibodies for private sale in Bangladesh; center around state campaigns

    Bangladesh’s Beximco Pharmaceuticals Ltd said on Thursday the Serum Institute of India (SII) had delayed the first supplies of a COVID-19 vaccine for personal sale, instead prioritising government immunisation campaigns. Beximco is Bangladesh’s exclusive distributor of the Oxford University-AstraZeneca shot that SII, the world’s biggest vaccine maker, is producing in bulk for low- and medium-income

    Sulforaphane draws out life expectancy and healthspan of C. elegans through insulin/IGF-1 flagging

    Aging-US released”Sulforaphane boosts C. elegans longevity and healthspan through DAF- 16/DAF-2 insulin/IGF-1 signaling” which reported that the broccoli-derived isothiocyanate sulforaphane inhibits inflammation, oxidative stress and cancer, but its impact on healthspan and longevity are unclear. The writers used the C. elegans nematode version and fed the wildtype and 9 mutant strains ±sulforaphane. Sulforaphane increased the

    Johnson and Johnson files COVID-19 immunization application with US FDA

    Johnson & Johnson said it has asked US health regulators to authorize its single-dose COVID-19 vaccine for emergency use, and it’ll apply to European authorities in coming weeks. The drugmaker’s application to the U.S. Food and Drug Administration (FDA) follows its Jan. 29 report where it said the vaccine had a 66% rate of preventing